UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension

PloS one, 2021-01, Vol.16 (1), p.e0245752-e0245752

2021

Link zum Volltext

Verfügbarkeit prüfen

Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial

PloS one, 2018-03, Vol.13 (3), p.e0193226-e0193226

2018

Link zum Volltext

Verfügbarkeit prüfen

Correction: Jansa et al. Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension. J. Clin. Med. 2022, 11 , 6189

Journal of clinical medicine, 2023-06, Vol.12 (12), p.3939

2023

Link zum Volltext

Verfügbarkeit prüfen

Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases

Circulation Cardiovascular quality and outcomes, 2019-05, Vol.12 (5), p.e005095-e005095

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-term Riociguat Treatment in Inoperable and Persistent/Recurrent CTEPH Patients in WHO Functional Class (FC) I/II Versus FC III/IV at Baseline: Results From the 16-Week Phase III CHEST-1 Study and CHEST-2 Open-Label Extension

Chest, 2014-03, Vol.145 (3), p.535B-1-535B-3

2014

Link zum Volltext

Verfügbarkeit prüfen

Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): 1-Year Results from the CHEST-2 Long-term Extension Study

Chest, 2013, Vol.144 (4), p.1023A-1023B

2013

Link zum Volltext

Verfügbarkeit prüfen

Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study

Chest, 2014-11, Vol.146 (5), p.1274-1285

2014

Link zum Volltext

Verfügbarkeit prüfen

PO-02-099 RADIOFREQUENCY CATHETER ABLATION OF ATRIAL TACHYCARDIA AND ATRIAL FIBRILLATION IN PATIENTS WITH PULMONARY HYPERTENSION. A SUBANALYSIS OF A PROSPECTIVE RANDOMIZED TRIAL

Heart rhythm, 2023-05, Vol.20 (5), p.S349-S349

2023

Link zum Volltext

Verfügbarkeit prüfen

AB-452666-2 CATHETER ABLATION OF ATRIAL FIBRILLATION AND ATRIAL TACHYCARDIA IN PATIENTS WITH PULMONARY HYPERTENSION: A RANDOMISED STUDY

Heart rhythm, 2023-05, Vol.20 (5), p.S97-S97

2023

Link zum Volltext

Verfügbarkeit prüfen

Surgical Treatment of Chronic Tromboembolic Pulmonary Hypertension - Combined Surgical Procedures

General Thoracic and Cardiovascular Surgery, 2017, Vol.65 (suppl), p.450-450

2017

Link zum Volltext

Verfügbarkeit prüfen

Case‑report: Paget‑Schrötter syndrome as a cause of chronic thromboembolic pulmonary hypertension

Vnitřní lékar̆stvĭ, 2023-10, Vol.69 (7), p.430-432

2023

Link zum Volltext

Verfügbarkeit prüfen

Development of interest of pulmonary hypertension in the Czech Republic

Vnitřní lékar̆stvĭ, 2014-04, Vol.60 (4), p.271-274

Jansa, Pavel

2014

Link zum Volltext

Verfügbarkeit prüfen

Benefits from catheter ablation in patients with pulmonary hypertension: Recent advances

Kardiologia polska (1957), 2024-06, Vol.82 (6), p.602-608

2024

Link zum Volltext

Verfügbarkeit prüfen

Effect of Macitentan on Hospitalizations

JACC. Heart failure, 2015, Vol.3 (1), p.1-8

2015

Link zum Volltext

Verfügbarkeit prüfen

Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension : BENEFiT (Bosentan Effects in iNopErable Forms of chronic Thromboembolic pulmonary hypertension), a Randomized, Placebo-Controlled Trial

Journal of the American College of Cardiology, 2008-12, Vol.52 (25), p.2127-2134

2008

Link zum Volltext

Verfügbarkeit prüfen

Doporučené postupy Evropské kardiologické společnosti (ESC) pro diagnostiku a léčbu akutní plicní embolie, verze 2019.Stručný přehled vypracovaný Českou kardiologickou společností

Cor et vasa (English ed.), 2020-05, Vol.62 (2), p.154-182

2020

Link zum Volltext

Verfügbarkeit prüfen

MACITENTAN TREATMENT EFFECT IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION TAKING SPIRONOLACTONE: POST-HOC ANALYSIS OF THE PHASE 3 SERAPHIN TRIAL

Chest, 2021-10, Vol.160 (4), p.A2284-A2286

2021

Link zum Volltext

Verfügbarkeit prüfen

EFFECT OF RIOCIGUAT ON RIGHT VENTRICULAR FUNCTION IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION

Chest, 2018-10, Vol.154 (4), p.1065A-1066A

2018

Link zum Volltext

Verfügbarkeit prüfen

Drug therapy of pulmonary arterial hypertension in 2014

Vnitřní lékar̆stvĭ, 2014-04, Vol.60 (4), p.282-288

2014

Link zum Volltext

Verfügbarkeit prüfen

SAFETY AND EFFICACY OF MACITENTAN IN ELDERLY PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH): INSIGHTS FROM SERAPHIN

Journal of the American College of Cardiology, 2020-03, Vol.75 (11), p.2090-2090

2020

Link zum Volltext

Verfügbarkeit prüfen

Surgical treatment of chronic thromboembolic pulmonary hypertension

Vnitřní lékar̆stvĭ, 2019, Vol.65 (5), p.353-358

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 54

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(48)
Tagungsberichte
(6)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(9)
Pulmonary/respiratory
(7)
Female
(6)
Male
(6)
Science & Technology
(6)
Middle Aged
(5)
Pulmonary Hypertension
(5)
Treatment Outcome
(5)
Hypertension, Pulmonary - Drug Therapy
(4)
Physical Sciences
(4)
Adult
(3)
Aged
(3)
Chemistry
(3)
Disease Progression
(3)
Dose-Response Relationship, Drug
(3)
Double-Blind Method
(3)
Patient Outcomes
(3)
Physics
(3)
Physics, Applied
(3)
Pulmonary Arterial Hypertension
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension

Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial

Correction: Jansa et al. Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension. J. Clin. Med. 2022, 11 , 6189

Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases

Long-term Riociguat Treatment in Inoperable and Persistent/Recurrent CTEPH Patients in WHO Functional Class (FC) I/II Versus FC III/IV at Baseline: Results From the 16-Week Phase III CHEST-1 Study and CHEST-2 Open-Label Extension

Do parameters of cardiac function predict long-term outcomes in patients with pulmonary arterial hypertension? Data from SERAPHIN, a randomized controlled study of macitentan

Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy

Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): 1-Year Results from the CHEST-2 Long-term Extension Study

Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study

Effect of Macitentan on Morbidity and Mortality in Pulmonary Arterial Hypertension (PAH): Results From the SERAPHIN Trial

PO-02-099 RADIOFREQUENCY CATHETER ABLATION OF ATRIAL TACHYCARDIA AND ATRIAL FIBRILLATION IN PATIENTS WITH PULMONARY HYPERTENSION. A SUBANALYSIS OF A PROSPECTIVE RANDOMIZED TRIAL

AB-452666-2 CATHETER ABLATION OF ATRIAL FIBRILLATION AND ATRIAL TACHYCARDIA IN PATIENTS WITH PULMONARY HYPERTENSION: A RANDOMISED STUDY

Surgical Treatment of Chronic Tromboembolic Pulmonary Hypertension - Combined Surgical Procedures

Case‑report: Paget‑Schrötter syndrome as a cause of chronic thromboembolic pulmonary hypertension

Development of interest of pulmonary hypertension in the Czech Republic

Benefits from catheter ablation in patients with pulmonary hypertension: Recent advances

Effect of Macitentan on Hospitalizations

Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension : BENEFiT (Bosentan Effects in iNopErable Forms of chronic Thromboembolic pulmonary hypertension), a Randomized, Placebo-Controlled Trial

Doporučené postupy Evropské kardiologické společnosti (ESC) pro diagnostiku a léčbu akutní plicní embolie, verze 2019.Stručný přehled vypracovaný Českou kardiologickou společností

MACITENTAN TREATMENT EFFECT IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION TAKING SPIRONOLACTONE: POST-HOC ANALYSIS OF THE PHASE 3 SERAPHIN TRIAL

EFFECT OF RIOCIGUAT ON RIGHT VENTRICULAR FUNCTION IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial

Drug therapy of pulmonary arterial hypertension in 2014

SAFETY AND EFFICACY OF MACITENTAN IN ELDERLY PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH): INSIGHTS FROM SERAPHIN

Surgical treatment of chronic thromboembolic pulmonary hypertension

Aktive Filter

Suchergebnisse filtern